Introductory investigations of dermatologic diode laser with wavelengths 975 nm: clinical therapy of Recklinghausen disease and of hemangiomas

摘要

The newly developed pulsed/cw dermatological laser (with wavelengths 975 nm) is applied for therapies requiring deep penetration of tissue e.g. cutaneous (dermal) neurofibroma (Recklinghausen disease) or hemangiomas. As the selected eight patients had been treated previously using pulsed a Nd:YAG laser a comparison of these therapies was possible. The results of cutaneous neurofibroma therapy using diode laser show an improvement compared with the case of Ho:YAG and Nd:YAG laser therapies - however this should be checked for a larger number of patients.